Holen Sie sich die Stockscreener-App
0.342
3.76%
-0.0169
T 2 Biosystems Inc Aktie (TTOO) Neueste Nachrichten
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com - Defense World
T2 Biosystems sells four T2Dx Instruments to European distributor - MSN
Before You Invest, Make Sure You Check This T2 Biosystems Inc (NASDAQ: TTOO) Analysis - Stocks Register
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor - citybiz
T2 Biosystems Expands International Market Presence with Sale of Four T2Dx® Instruments to European Distributor - Nasdaq
T2 Biosystems expands EU presence with instrument sales - Investing.com
T2 Biosystems Expands European Footprint with Strategic T2Dx Instrument Sales, Breakthrough Clinical Data - StockTitan
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally - The Manila Times
T2 Biosystems' Revolutionary Sepsis Tests Hit 250K Milestone, Slash Detection Time by 77 Hours - StockTitan
T2 Biosystems extends Vizient supplier agreement By Investing.com - Investing.com Canada
T2 Biosystems extends Vizient supplier agreement - Investing.com India
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc - Marketscreener.com
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. - The Manila Times
T2 Biosystems stock plunges to 52-week low of $0.41 By Investing.com - Investing.com South Africa
T2 Biosystems faces Nasdaq delisting over share price - Investing.com
T2 Biosystems stock plunges to 52-week low of $0.41 - Investing.com
T2 Biosystems expands its leadership in direct-from-whole-blood detection of sepsis-causing pathogens - SelectScience
T2 Biosystems to license sepsis detection tech By Investing.com - Investing.com Canada
T2 Biosystems to license sepsis detection tech - Investing.com India
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens - The Manila Times
T2 Biosystems Announces Plans to License its Proprietary - GlobeNewswire
T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com - Defense World
T2 Biosystems Inc (NASDAQ: TTOO) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems stock plunges to 52-week low of $0.44 By Investing.com - Investing.com Canada
T2 Biosystems stock plunges to 52-week low of $0.44 - Investing.com
T2 Biosystems Reports Strong Q3 Financial Results and Operational Updates - Defense World
T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2024 Earnings Call Transcript - Insider Monkey
T2 Biosystems: Q3 Earnings Snapshot - mySA
Earnings call: T2 Biosystems reports growth and strategic partnerships - Investing.com
Earnings call: T2 Biosystems reports growth and strategic partnerships By Investing.com - Investing.com UK
Analysis of ARMISTICE CAPITAL, LLC's Recent Trade in T2 Biosyste - GuruFocus.com
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
T2 Biosystems Reports Increased Losses and Cash Crunch - TipRanks
T2 Biosystems Inc (TTOO) Quarterly 10-Q Report - Quartz
T2 Biosystems Announces Third Quarter 2024 Financial Results - The Manila Times
T2 Biosystems Reports 34% Revenue Growth, Signs Cardinal Health Distribution Deal | TTOO Stock News - StockTitan
T2 Biosystems stock plunges to 52-week low of $0.55 - Investing.com India
T2 Biosystems stock plunges to 52-week low of $0.55 By Investing.com - Investing.com Canada
500: Something went wrong - Investing.com
T2 Biosystems Faces Potential Delisting from Nasdaq due to Market Value - Defense World
0.69%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):